B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis

被引:5
|
作者
Gagelmann, Nico [1 ]
Ayuk, Francis Ayuketang [1 ]
Atanackovic, Djordje [2 ]
Kroeger, Nicolaus [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
关键词
D O I
10.1182/blood-2019-121967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3113
引用
收藏
页数:3
相关论文
共 50 条
  • [21] A Systematic Meta-Analysis of Cytokine Release Syndrome Incidence in B-Cell Maturation Antigen-Targeting Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Patients with Relapsed and/or Refractory Multiple Myeloma
    Sharma, Sheena
    Wang, Diane
    Lon, Hoi-Kei
    Soltantabar, Pooneh
    Viqueira, Andrea
    Czibere, Akos
    Hickman, Anne
    White, Jane Liang
    Elmeliegy, Mohamed
    BLOOD, 2022, 140 : 10036 - 10038
  • [22] Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials
    Xiang, Xinrong
    He, Qiao
    Ou, Yang
    Wang, Wen
    Wu, Yu
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [23] B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma
    Abramson, Hanley N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 24
  • [24] Infectious Complications of B-Cell Maturation Antigen (BCMA)-Targeted Therapies for Relapsed/Refractory Multiple Myeloma
    Hoeynck, Brian
    Hwang, Wei-Ting
    Garfall, Alfred L.
    Susanibar-Adaniya, Sandra Patricia
    Vogl, Dan T.
    Waxman, Adam
    Stadtmauer, Edward A.
    Cohen, Adam D.
    BLOOD, 2022, 140 : 10081 - 10083
  • [25] CAR-T Therapy in Relapsed Refractory Multiple Myeloma
    Ding, Hong
    Wu, Yu
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4362 - 4382
  • [26] Sustainable Efficacy and Safety Results from Lummicar Study 1: A Phase 1/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma
    Chen, Wenming
    Fu, Chengcheng
    Cai, Zhen
    Li, Zonghai
    Wang, Huijuan
    Yan, Lingzhi
    Wu, Yin
    Shi, Xiaolan
    Gao, Wen
    Yan, Shuang
    Wang, Wei
    Han, Xiaoyan
    Zheng, Gaofeng
    Wen, Yanling
    Xiao, Jun
    Wang, Huamao
    Tang, Xiaole
    BLOOD, 2021, 138
  • [27] CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
    Mishra, Abhinava K.
    Gupta, Ashna
    Dagar, Gunjan
    Das, Dayasagar
    Chakraborty, Abhijit
    Haque, Shabirul
    Prasad, Chandra Prakash
    Singh, Archana
    Bhat, Ajaz A.
    Macha, Muzafar A.
    Benali, Moez
    Saini, Kamal S.
    Previs, Rebecca Ann
    Saini, Deepak
    Saha, Dwaipayan
    Dutta, Preyangsee
    Bhatnagar, Aseem Rai
    Darswal, Mrinalini
    Shankar, Abhishek
    Singh, Mayank
    VACCINES, 2023, 11 (11)
  • [28] Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.
    Fan, Frank
    Zhao, Wanhong
    Liu, Jie
    He, Aili
    Chen, Yinxia
    Cao, Xingmei
    Yang, Nan
    Wang, Baiyan
    Zhang, Pengyu
    Zhang, Yilin
    Wang, Fangxia
    Lei, Bo
    Gu, Liufang
    Wang, Xugeng
    Zhuang, Qiuchuan
    Zhang, Wanggang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18)
  • [29] Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.
    Fan, Frank
    Zhao, Wanhong
    Liu, Jie
    He, Aili
    Chen, Yinxia
    Cao, Xingmei
    Yang, Nan
    Wang, Baiyan
    Zhang, Pengyu
    Zhang, Yilin
    Wang, Fangxia
    Lei, Bo
    Gu, Liufang
    Wang, Xugeng
    Zhuang, Qiuchuan
    Zhang, Wanggang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Advances in CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials in the Last Two Years
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Zubair, Hina
    Butt, Sigmone Khalid
    Anwar, Muhammad Yasir
    Hamza, Mohammad
    Nanjundaiah, Nikhilesh
    Chemarthi, Venkata Sireesha
    Shaaban, Hamid
    Guron, Gunwant
    Maroules, Michael
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S485 - S486